Immediate Impact

2 by Nobel laureates 6 from Science/Nature 57 standout
Sub-graph 1 of 24

Citing Papers

Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
2024 Standout
Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials
2024 Standout
2 intermediate papers

Works of James E. Ross being referenced

Determination of Disk Diffusion and MIC Quality Control Guidelines for GSK2140944, a Novel Bacterial Type II Topoisomerase Inhibitor Antimicrobial Agent
2014
Activity of Retapamulin (SB-275833), a Novel Pleuromutilin, against Selected Resistant Gram-Positive Cocci
2006
and 1 more

Author Peers

Author Last Decade Papers Cites
James E. Ross 960 615 344 436 38 1.3k
Peggy C. Kohner 623 518 450 285 32 1.3k
Brian J. Werth 810 479 277 286 49 1.3k
Klaudia Kosowska-Shick 700 256 313 373 35 1.1k
Jorgelina Smayevsky 941 544 396 578 46 1.7k
P E Coudron 437 371 663 235 37 1.4k
Anne Bolmström 924 419 313 333 25 1.3k
Óscar Cuevas 480 290 440 283 41 1.2k
Manuela Carugati 818 276 168 668 34 1.7k
Jennifer K. Bender 707 409 358 409 49 1.3k
Marco Ligozzi 884 426 242 285 51 1.3k

All Works

Loading papers...

Rankless by CCL
2026